tacrine has been researched along with huperzine a in 39 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 10 (25.64) | 18.2507 |
2000's | 20 (51.28) | 29.6817 |
2010's | 7 (17.95) | 24.3611 |
2020's | 2 (5.13) | 2.80 |
Authors | Studies |
---|---|
Brossi, A; Greig, NH; Holloway, HW; Whittaker, NF; Yu, QS; Zhu, X | 1 |
Badia, A; Camps, P; Clos, MV; Formosa, X; Muñoz-Torrero, D; Petrignet, J | 1 |
Brossi, A; Greig, NH; Holloway, HW; Kulkarni, SS; Lahiri, DK; Luo, W; Parrish, DA; Shafferman, A; Tweedie, D; Yu, QS | 1 |
Belinskaya, T; Borriello, M; Butini, S; Campiani, G; Catalanotti, B; De Angelis, M; Fattorusso, C; Gabellieri, E; Gemma, S; Huleatt, P; Nacci, V; Novellino, E; Saxena, A | 1 |
Al-Rashid, ZF; Beri, V; Cheung, J; Rosenberry, TL; Shiomi, K; Wildman, SA | 1 |
Cheng, DH; Ren, H; Tang, XC | 1 |
Badia, A; Baños, JE; Camps, P; Contreras, J; Görbig, DM; Muñoz-Torrero, D; Simón, M; Vivas, NM | 1 |
Cheng, DH; Tang, XC | 1 |
Tang, XC; Wang, T | 1 |
Ariel, N; Barak, D; Bino, T; Ordentlich, A; Shafferman, A; Velan, B | 1 |
Hu, GY; Lin, JH; Tang, XC | 1 |
Tang, XC; Wang, H | 1 |
Badia, A; Barril, X; Camps, P; El Achab, R; Eladi Baños, J; Görbig, DM; Luque, FJ; Morral, J; Muñoz-Torrero, D; Orozco, M; Vivas, NM | 1 |
Carlier, PR; Du, DM; Han, Y; Liu, J; Pang, YP | 1 |
Barril, X; Luque, FJ; Orozco, M | 1 |
Kaur, J; Zhang, MQ | 1 |
Tang, XC; Wang, R; Xiao, XQ | 1 |
Badia, A; Baños, JE; Barril, X; Camps, P; Luque, FJ; Morral, J; Muñoz-Torrero, D; Orozco, M; Vivas, NM | 1 |
Barril, X; Camps, P; Dvir, H; Harel, M; Luque, FJ; Muñoz-Torrero, D; Orozco, M; Rosenberry, TL; Silman, I; Sussman, JL; Wong, DM | 1 |
Camps, P; Muñoz-Torrero, D | 1 |
Tang, XC; Zhao, Q | 1 |
Bai, DL; Jin, GY; Xia, Y | 1 |
Ma, XC; Tu, ZH; Wang, HX; Xin, J; Zhang, T | 1 |
Alcalá, Mdel M; Badia, A; Camps, P; Hospital, S; Muñoz-Torrero, D; Vivas, NM | 1 |
Bai, D; He, X; Jiang, H; Jin, G; Luo, X; Zhang, H | 1 |
Camins, A; Camps, P; Canudas, AM; Jiménez, A; Jordá, EG; Muñoz-Torrero, D; Pallàs, M; Rimbau, V; Verdaguer, E | 1 |
Dong So, D; Han, Y; Law, SL; Xu, Z; Xue, H; Zheng, H | 1 |
Beck, C; Blank, K; Colenda, CC; Doraiswamy, MP; Kalunian, DA; Lyketsos, CG; Yaffe, K | 1 |
Caballero, J; Fernández, M | 1 |
Badia, A; Camps, P; Clos, MV; Curutchet, C; Gómez, E; Luque, FJ; Muñoz-Muriedas, J; Muñoz-Torrero, D | 1 |
Carlier, PR; Han, YF; Kan, KK; Li, WM; Pang, YP | 1 |
Abib, R; Gonçalves, CA; Guerra, MC; Leite, MC; Lunardi, P; Nardin, P | 1 |
Bautista-Aguilera, OM; Borrell, JI; Brogi, S; Butini, S; Cacabelos, R; Chioua, M; de la Bellacasa, RP; López, MG; Marco-Contelles, J; Pérez, M; Romero, A; Yañez, M | 1 |
Hou, B; Yang, H; Zhang, S; Zuo, Z | 1 |
Andrés, J; Nascimento, ÉCM; Oliva, M | 1 |
Chen, Q; Wang, Y; Xiao, X; Zhu, X | 1 |
Carlier, PR; Cui, W; Fu, H; Han, Y; Hu, S; Li, W; Luo, J; Mak, S; Pang, Y; Pi, R; Tsim, KW | 1 |
Gong, Q; Li, J; Li, X; Liu, W; Mao, F; Qiu, X; Wang, H; Wang, W; Xu, Y; Zhang, H; Zhang, J; Zhu, J | 1 |
Curtis, MA; Lin, SX; Sperry, J | 1 |
6 review(s) available for tacrine and huperzine a
Article | Year |
---|---|
Molecular modelling and QSAR of reversible acetylcholines-terase inhibitors.
Topics: Alkaloids; Alzheimer Disease; Cholinesterase Inhibitors; Crystallography, X-Ray; Donepezil; Drug Design; Glaucoma; Humans; Indans; Models, Molecular; Myasthenia Gravis; Neostigmine; Physostigmine; Piperidines; Sesquiterpenes; Structure-Activity Relationship; Surface Properties; Tacrine | 2000 |
Tacrine-huperzine A hybrids (huprines): a new class of highly potent and selective acetylcholinesterase inhibitors of interest for the treatment of Alzheimer's disease.
Topics: Alkaloids; Alzheimer Disease; Cholinesterase Inhibitors; Drug Design; Humans; Models, Molecular; Molecular Conformation; Sesquiterpenes; Structure-Activity Relationship; Tacrine | 2001 |
[Advances in search for acetylcholinesterase inhibitor based on the double active sites hypothesis].
Topics: Alkaloids; Cholinesterase Inhibitors; Donepezil; Indans; Molecular Conformation; Molecular Structure; Piperidines; Sesquiterpenes; Tacrine | 2002 |
East meets West in the search for Alzheimer's therapeutics - novel dimeric inhibitors from tacrine and huperzine A.
Topics: Alkaloids; Alzheimer Disease; Animals; Cholinesterase Inhibitors; Drugs, Chinese Herbal; Humans; Models, Biological; Sesquiterpenes; Tacrine | 2007 |
Promising tacrine/huperzine A-based dimeric acetylcholinesterase inhibitors for neurodegenerative disorders: From relieving symptoms to modifying diseases through multitarget.
Topics: Acetylcholinesterase; Alkaloids; Animals; Cholinesterase Inhibitors; Drug Combinations; Drug Delivery Systems; Humans; Neurodegenerative Diseases; Neuroprotective Agents; Sesquiterpenes; Tacrine | 2021 |
Pyridine alkaloids with activity in the central nervous system.
Topics: Alkaloids; Amphibians; Animals; Bacteria; Central Nervous System Diseases; Fungi; Nicotine; Plants; Pyridines; Receptors, Nicotinic | 2020 |
33 other study(ies) available for tacrine and huperzine a
Article | Year |
---|---|
Anticholinesterase activity of compounds related to geneserine tautomers. N-Oxides and 1,2-oxazines.
Topics: Acetylcholinesterase; Alkaloids; Butyrylcholinesterase; Cholinesterase Inhibitors; Cyclic N-Oxides; Humans; Isomerism; Oxazines; Structure-Activity Relationship | 2002 |
Synthesis and pharmacological evaluation of huprine-tacrine heterodimers: subnanomolar dual binding site acetylcholinesterase inhibitors.
Topics: Acetylcholinesterase; Aminoquinolines; Animals; Binding Sites; Butyrylcholinesterase; Cattle; Cholinesterase Inhibitors; Heterocyclic Compounds, 4 or More Rings; Humans; Structure-Activity Relationship; Tacrine | 2005 |
Inhibition of human acetyl- and butyrylcholinesterase by novel carbamates of (-)- and (+)-tetrahydrofurobenzofuran and methanobenzodioxepine.
Topics: Acetophenones; Acetylcholinesterase; Animals; Benzofurans; Butyrylcholinesterase; Carbamates; Cholinesterase Inhibitors; Crystallography, X-Ray; Furans; Heterocyclic Compounds, 3-Ring; Humans; Models, Molecular; Oxepins; Stereoisomerism; Structure-Activity Relationship; Torpedo | 2006 |
Discovery of huperzine A-tacrine hybrids as potent inhibitors of human cholinesterases targeting their midgorge recognition sites.
Topics: Acetylcholinesterase; Alkaloids; Binding Sites; Butyrylcholinesterase; Catalytic Domain; Cholinesterase Inhibitors; Humans; Models, Molecular; Protein Binding; Sesquiterpenes; Stereoisomerism; Structure-Activity Relationship; Tacrine | 2006 |
The natural product dihydrotanshinone I provides a prototype for uncharged inhibitors that bind specifically to the acetylcholinesterase peripheral site with nanomolar affinity.
Topics: Acetylcholine; Acetylcholinesterase; Aflatoxin B1; Binding Sites; Binding, Competitive; Catalysis; Catalytic Domain; Cholinesterase Inhibitors; Crystallography, X-Ray; Furans; Humans; Hydrolysis; Kinetics; Models, Chemical; Phenanthrenes; Pyrans; Quinones; Recombinant Proteins; Structure-Activity Relationship; Substrate Specificity | 2013 |
Huperzine A, a novel promising acetylcholinesterase inhibitor.
Topics: Acetylcholinesterase; Alkaloids; Amnesia; Animals; Butyrylcholinesterase; Cerebral Cortex; Cholinergic Antagonists; Cholinesterase Inhibitors; Donepezil; Indans; Kinetics; Male; Maze Learning; Memory; Memory, Short-Term; Piperidines; Rats; Rats, Sprague-Dawley; Scopolamine; Sesquiterpenes; Tacrine | 1996 |
Synthesis and evaluation of tacrine-huperzine A hybrids as acetylcholinesterase inhibitors of potential interest for the treatment of Alzheimer's disease.
Topics: Acetylcholinesterase; Alkaloids; Alzheimer Disease; Animals; Cattle; Cholinesterase Inhibitors; Magnetic Resonance Spectroscopy; Male; Neuromuscular Junction; Neuroprotective Agents; Rats; Rats, Sprague-Dawley; Sesquiterpenes; Spectrophotometry, Infrared; Tacrine | 1998 |
Comparative studies of huperzine A, E2020, and tacrine on behavior and cholinesterase activities.
Topics: Alkaloids; Animals; Aziridines; Choline; Choline O-Acetyltransferase; Cholinesterase Inhibitors; Cholinesterases; Donepezil; Dose-Response Relationship, Drug; Female; Indans; Injections, Intraventricular; Male; Maze Learning; Memory; Memory, Short-Term; Neuromuscular Blocking Agents; Piperidines; Rats; Rats, Sprague-Dawley; Sesquiterpenes; Tacrine | 1998 |
Reversal of scopolamine-induced deficits in radial maze performance by (-)-huperzine A: comparison with E2020 and tacrine.
Topics: Alkaloids; Amnesia; Animals; Cholinesterase Inhibitors; Donepezil; Indans; Male; Maze Learning; Muscarinic Antagonists; Nootropic Agents; Piperidines; Rats; Rats, Sprague-Dawley; Scopolamine; Sesquiterpenes; Tacrine | 1998 |
The 'aromatic patch' of three proximal residues in the human acetylcholinesterase active centre allows for versatile interaction modes with inhibitors.
Topics: Acetylcholinesterase; Alkaloids; Binding Sites; Cholinesterase Inhibitors; Crystallography, X-Ray; Humans; Hydrogen Bonding; Kinetics; Ligands; Models, Chemical; Models, Molecular; Physostigmine; Protein Conformation; Pyridostigmine Bromide; Sesquiterpenes; Structure-Activity Relationship; Tacrine | 1998 |
Comparison between huperzine A, tacrine, and E2020 on cholinergic transmission at mouse neuromuscular junction in vitro.
Topics: Action Potentials; Alkaloids; Animals; Cholinesterase Inhibitors; Donepezil; Female; Indans; Male; Membrane Potentials; Mice; Muscle Fibers, Skeletal; Neuromuscular Junction; Phrenic Nerve; Piperidines; Sesquiterpenes; Tacrine | 1997 |
Anticholinesterase effects of huperzine A, E2020, and tacrine in rats.
Topics: Acetylcholinesterase; Alkaloids; Animals; Brain; Butyrylcholinesterase; Cholinesterase Inhibitors; Donepezil; Dose-Response Relationship, Drug; Female; In Vitro Techniques; Indans; Male; Piperidines; Rats; Rats, Sprague-Dawley; Sesquiterpenes; Tacrine | 1998 |
Synthesis, in vitro pharmacology, and molecular modeling of very potent tacrine-huperzine A hybrids as acetylcholinesterase inhibitors of potential interest for the treatment of Alzheimer's disease.
Topics: Acetylcholinesterase; Alkaloids; Animals; Binding Sites; Cholinesterase Inhibitors; Diaphragm; In Vitro Techniques; Male; Models, Molecular; Muscle Contraction; Neuromuscular Junction; Neuroprotective Agents; Phrenic Nerve; Quinolines; Rats; Rats, Sprague-Dawley; Sesquiterpenes; Stereoisomerism; Structure-Activity Relationship; Tacrine; Torpedo | 1999 |
Potent, easily synthesized huperzine A-tacrine hybrid acetylcholinesterase inhibitors.
Topics: Acetylcholinesterase; Alkaloids; Cholinesterase Inhibitors; Sesquiterpenes; Tacrine | 1999 |
Predicting relative binding free energies of tacrine-huperzine A hybrids as inhibitors of acetylcholinesterase.
Topics: Acetylcholinesterase; Alkaloids; Amino Acid Substitution; Animals; Cholinesterase Inhibitors; Neuroprotective Agents; Protein Binding; Sesquiterpenes; Tacrine; Thermodynamics; Torpedo | 1999 |
Huperzine A and tacrine attenuate beta-amyloid peptide-induced oxidative injury.
Topics: Alkaloids; Alzheimer Disease; Amyloid beta-Peptides; Animals; Catalase; Cell Survival; Cells, Cultured; Cerebral Cortex; Cholinesterase Inhibitors; Dose-Response Relationship, Drug; Glutathione Peroxidase; Lipid Peroxidation; Malondialdehyde; Neurons; Neuroprotective Agents; Oxidative Stress; PC12 Cells; Peptide Fragments; Rats; Rats, Wistar; Sesquiterpenes; Superoxide Dismutase; Tacrine | 2000 |
New tacrine-huperzine A hybrids (huprines): highly potent tight-binding acetylcholinesterase inhibitors of interest for the treatment of Alzheimer's disease.
Topics: Acetylcholinesterase; Alkaloids; Alzheimer Disease; Animals; Bridged Bicyclo Compounds; Butyrylcholinesterase; Cattle; Cholinesterase Inhibitors; Humans; In Vitro Techniques; Male; Mice; Models, Molecular; Neuromuscular Junction; Neuromuscular Nondepolarizing Agents; Neuroprotective Agents; Quinolines; Rats; Rats, Sprague-Dawley; Sesquiterpenes; Stereoisomerism; Structure-Activity Relationship; Tacrine; Tubocurarine | 2000 |
3D structure of Torpedo californica acetylcholinesterase complexed with huprine X at 2.1 A resolution: kinetic and molecular dynamic correlates.
Topics: Acetylcholinesterase; Alkaloids; Aminoquinolines; Animals; Binding Sites; Chlorine; Cholinesterase Inhibitors; Computer Simulation; Crystallization; Crystallography, X-Ray; Heterocyclic Compounds, 4 or More Rings; Kinetics; Ligands; Models, Molecular; Protein Conformation; Sesquiterpenes; Species Specificity; Tacrine; Torpedo | 2002 |
Effects of huperzine A on acetylcholinesterase isoforms in vitro: comparison with tacrine, donepezil, rivastigmine and physostigmine.
Topics: Acetylcholinesterase; Alkaloids; Animals; Carbamates; Cerebral Cortex; Cholinesterase Inhibitors; Corpus Striatum; Donepezil; Hippocampus; Indans; Isoenzymes; Kinetics; Male; Phenylcarbamates; Physostigmine; Piperidines; Rats; Rats, Sprague-Dawley; Rivastigmine; Sesquiterpenes; Tacrine | 2002 |
Acute effects of huperzine A and tacrine on rat liver.
Topics: Alanine Transaminase; Alkaloids; Animals; Aspartate Aminotransferases; Cholinesterase Inhibitors; Female; Hepatocytes; L-Lactate Dehydrogenase; Liver; Male; Rats; Rats, Sprague-Dawley; Sesquiterpenes; Tacrine | 2003 |
Characterisation of the anticholinesterase activity of two new tacrine-huperzine A hybrids.
Topics: Alkaloids; Aminoquinolines; Animals; Brain; Butyrylcholinesterase; Cattle; Cholinesterase Inhibitors; Heterocyclic Compounds, 4 or More Rings; Humans; Mice; Sesquiterpenes; Stereoisomerism; Structure-Activity Relationship; Tacrine | 2003 |
Synthesis and docking studies of alkylene-linked dimers of (-)-huperzine A.
Topics: Alkaloids; Alkylation; Binding Sites; Cholinesterase Inhibitors; Indicators and Reagents; Polymers; Protein Conformation; Sesquiterpenes; Tacrine | 2003 |
(+/-)-huprine Y, (-)-huperzine A and tacrine do not show neuroprotective properties in an apoptotic model of neuronal cytoskeletal alteration.
Topics: Alkaloids; Alzheimer Disease; Aminoquinolines; Animals; Animals, Newborn; Apoptosis; Cerebellum; Cholinesterase Inhibitors; Colchicine; Cytoskeleton; Disease Models, Animal; Flow Cytometry; Glycogen Synthase Kinase 3; Heterocyclic Compounds, 4 or More Rings; Neurons; Neuroprotective Agents; Rats; Rats, Sprague-Dawley; Sesquiterpenes; Tacrine | 2004 |
Effects of a memory enhancing peptide on cognitive abilities of brain-lesioned mice: additivity with huperzine A and relative potency to tacrine.
Topics: Alkaloids; Animals; Avoidance Learning; Behavior, Animal; Brain Diseases; Cognition Disorders; Disease Models, Animal; Dose-Response Relationship, Drug; Male; Maze Learning; Memory; Mice; Peptide Fragments; Scopolamine; Sesquiterpenes; Tacrine | 2006 |
Position statement of the American Association for Geriatric Psychiatry regarding principles of care for patients with dementia resulting from Alzheimer disease.
Topics: Aged; Alkaloids; Alzheimer Disease; Brain; Caregivers; Cholinesterase Inhibitors; Cognition Disorders; Dementia; Diagnostic and Statistical Manual of Mental Disorders; Galantamine; Geriatric Psychiatry; Health Services for the Aged; Humans; Phenylcarbamates; Professional-Family Relations; Rivastigmine; Sesquiterpenes; Tacrine; United States | 2006 |
Ensembles of Bayesian-regularized genetic neural networks for modeling of acetylcholinesterase inhibition by huprines.
Topics: Acetylcholinesterase; Algorithms; Alkaloids; Animals; Bayes Theorem; Cattle; Cholinesterase Inhibitors; Computer Simulation; Drug Design; Models, Biological; Molecular Structure; Neural Networks, Computer; Quantitative Structure-Activity Relationship; Sesquiterpenes; Tacrine | 2006 |
Binding of 13-amidohuprines to acetylcholinesterase: exploring the ligand-induced conformational change of the gly117-gly118 peptide bond in the oxyanion hole.
Topics: Acetylcholinesterase; Alkaloids; Aminoquinolines; Animals; Anions; Catalytic Domain; Cattle; Cholinesterase Inhibitors; Erythrocytes; Formamides; Glycine; Heterocyclic Compounds, 4 or More Rings; Humans; Ligands; Models, Molecular; Protein Binding; Protein Conformation; Sesquiterpenes; Stereoisomerism; Structure-Activity Relationship; Sulfonamides; Tacrine | 2006 |
Huperzine A, but not tacrine, stimulates S100B secretion in astrocyte cultures.
Topics: Alkaloids; Animals; Astrocytes; Cell Survival; Cells, Cultured; Cholinesterase Inhibitors; Dementia; Hippocampus; Male; Nerve Growth Factors; Neuroprotective Agents; Rats; Rats, Wistar; S100 Calcium Binding Protein beta Subunit; S100 Proteins; Sesquiterpenes; Tacrine | 2013 |
Development of HuperTacrines as non-toxic, cholinesterase inhibitors for the potential treatment of Alzheimer's disease.
Topics: Acetylcholinesterase; Alkaloids; Alzheimer Disease; Cholinesterase Inhibitors; Cholinesterases; Drug Discovery; Hep G2 Cells; Humans; Models, Molecular; Nootropic Agents; Sesquiterpenes; Tacrine | 2015 |
Design and prediction of new acetylcholinesterase inhibitor via quantitative structure activity relationship of huprines derivatives.
Topics: Alkaloids; Aminoquinolines; Cholinesterase Inhibitors; Drug Design; Heterocyclic Compounds, 4 or More Rings; Molecular Docking Simulation; Molecular Structure; Predictive Value of Tests; Quantitative Structure-Activity Relationship; Sesquiterpenes; Tacrine | 2016 |
Binding free energy calculations to rationalize the interactions of huprines with acetylcholinesterase.
Topics: Acetylcholinesterase; Alkaloids; Binding Sites; Cholinesterase Inhibitors; Molecular Dynamics Simulation; Protein Binding; Protein Conformation; Sesquiterpenes; Tacrine; Thermodynamics | 2018 |
ABAD/17β-HSD10 reduction contributes to the protective mechanism of huperzine a on the cerebral mitochondrial function in APP/PS1 mice.
Topics: 3-Hydroxyacyl CoA Dehydrogenases; Alkaloids; Alzheimer Disease; Amyloid beta-Peptides; Animals; Brain; Cell Survival; Cytochromes c; Disease Models, Animal; Male; Mice, Transgenic; Mitochondria; Neuroprotective Agents; Reactive Oxygen Species; Sesquiterpenes; Tacrine | 2019 |
Design, synthesis and evaluation of vilazodone-tacrine hybrids as multitarget-directed ligands against depression with cognitive impairment.
Topics: Acetylcholinesterase; Alzheimer Disease; Animals; Blood-Brain Barrier; Butyrylcholinesterase; Cholinesterase Inhibitors; Depression; Drug Design; Ligands; Mice; Permeability; Serotonin 5-HT1 Receptor Agonists; Structure-Activity Relationship; Tacrine; Vilazodone Hydrochloride | 2018 |